ZNF550 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.014000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.572800E-01
Normal-vs-Stage2
4.881600E-01
Normal-vs-Stage3
2.760600E-01
Normal-vs-Stage4
9.557400E-01
Stage1-vs-Stage2
4.591600E-02
Stage1-vs-Stage3
7.595200E-03
Stage1-vs-Stage4
6.645400E-01
Stage2-vs-Stage3
1.13609999996545E-06
Stage2-vs-Stage4
2.947700E-02
Stage3-vs-Stage4
2.158400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.086000E-01
Normal-vs-AfricanAmerican
4.943000E-01
Normal-vs-Asian
1.462980E-01
Caucasian-vs-AfricanAmerican
8.705400E-01
Caucasian-vs-Asian
3.468800E-01
AfricanAmerican-vs-Asian
6.433200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.867200E-01
Normal-vs-Female
5.225600E-01
Male-vs-Female
5.075000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.734600E-01
Normal-vs-Age(41-60Yrs)
6.284000E-01
Normal-vs-Age(61-80Yrs)
4.569600E-01
Normal-vs-Age(81-100Yrs)
3.718200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.234400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.982600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.815700E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.497500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.283510E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.845600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.207400E-01
Normal-vs-Daily Drinker
4.373200E-01
Normal-vs-Weekly Drinker
4.160200E-01
Normal-vs-Occasional Drinker
5.127400E-01
Normal-vs-Social Drinker
5.450800E-01
Non Drinker-vs-Daily Drinker
8.505000E-01
Non Drinker-vs-Weekly Drinker
9.335000E-01
Non Drinker-vs-Occasional Drinker
1.372290E-02
Non Drinker-vs-Social Drinker
2.188400E-01
Daily Drinker-vs-Weekly Drinker
8.200400E-01
Daily Drinker-vs-Occasional Drinker
4.562500E-02
Daily Drinker-vs-Social Drinker
3.604800E-01
Weekly Drinker-vs-Occasional Drinker
4.006400E-02
Weekly Drinker-vs-Social Drinker
2.639200E-01
Occasional Drinker-vs-Social Drinker
3.132400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.282800E-01
Normal-vs-Grade 2
2.120000E-01
Normal-vs-Grade 3
2.414600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.393400E-01
Grade 1-vs-Grade 3
3.889200E-01
Grade 1-vs-Grade 4
3.282800E-01
Grade 2-vs-Grade 3
6.264000E-01
Grade 2-vs-Grade 4
2.120000E-01
Grade 3-vs-Grade 4
2.414600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.411000E-01
Normal-vs-NonDiabetic
4.865800E-01
Diabetic-vs-NonDiabetic
4.117000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.810000E-01
Normal-vs-NoPancreatitis
4.846600E-01
Pancreatitis-vs-NoPancreatitis
1.945830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.742450E-01
Normal-vs-N1
4.884400E-01
N0-vs-N1
7.196200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.368400E-01
Normal-vs-TP53-NonMutant
5.773800E-01
TP53-Mutant-vs-TP53-NonMutant
6.207800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
